Operating Lease, Right-of-Use Asset of Kiromic Biopharma, Inc. from 31 Mar 2022 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Kiromic Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 31 Dec 2024.
Kiromic Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $913,000, a 41% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Kiromic Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$913,000	-$630,000	-41%	31 Dec 2024	10-K	14 Feb 2025	2024	FY
Q3 2024	$1,074,000	-$618,800	-37%	30 Sep 2024	10-Q	08 Nov 2024	2024	Q3
Q2 2024	$1,233,000	-$607,400	-33%	30 Jun 2024	10-Q	09 Aug 2024	2024	Q2
Q1 2024	$1,389,000	-$596,800	-30%	31 Mar 2024	10-Q	10 May 2024	2024	Q1
Q4 2023	$1,543,000	-$574,300	-27%	31 Dec 2023	10-K	14 Feb 2025	2024	FY
Q3 2023	$1,692,800	-$471,700	-22%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$1,840,400	-$457,900	-20%	30 Jun 2023	10-Q	14 Aug 2023	2023	Q2
Q1 2023	$1,985,800	-$241,500	-11%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$2,117,300			31 Dec 2022	10-K	19 Mar 2024	2023	FY
Q3 2022	$2,164,500			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$2,298,300			30 Jun 2022	10-Q	12 Aug 2022	2022	Q2
Q1 2022	$2,227,300			31 Mar 2022	10-Q	13 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.